Multimedia
Covid-19 put spotlight on vaccines, diagnostics: Mazumdar-Shaw
This pandemic has put vaccine development into the spotlight, Biocon chairperson and managing director Kiran Mazumdar-Shaw tells Fortune India. The segment has seen a lot of action of late after "languishing for many, many decades". The resurgence of interest and new technologies bring a refreshing change to vaccine development, and that is a huge opportunity for the biotech field, says Mazumdar-Shaw.
Also Read
-
One Nation, One Healthcare cost not practical: Centre
-
YES Bank shares skid over 3% amid block deal buzz
-
OECD upgrades India’s FY25 GDP growth forecast to 6.6%
-
Apple is making iPhones in India to be competitive: Tim Cook
-
Bajaj Finance shares jump 7% after RBI lifts ban on eCOM, Insta EMI Card